Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Jose, CA
NPI
1952833931
Since 2017
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2690 S White Rd Ste 50
San Jose, CA, 95148
Phone (408) 223-7000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.2M
6,234 prescriptions
Company payments, 2025
$3,388
From 26 companies
Medicare prescription drug claims, 2024
In 2024, the drug Thomas M Fandel prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 457 prescriptions and refills. In total Thomas M Fandel wrote 6,234 Medicare prescriptions that cost $3.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jardiance Empagliflozin | 457 | 984 | 127 | $555K |
| Atorvastatin Calcium Generic | 394 | 1,059 | 120 | $4,522 |
| Ozempic Semaglutide | 394 | 645 | 102 | $603K |
| Repaglinide Generic | 389 | 1,020 | 123 | $16K |
| Levothyroxine Sodium Generic | 381 | 984 | 102 | $6,090 |
| Metformin Hcl Generic | 356 | 976 | 122 | $3,190 |
| Trulicity Dulaglutide | 242 | 345 | 47 | $327K |
| Losartan Potassium Generic | 237 | 653 | 81 | $2,403 |
| Metformin Hcl Er Metformin Hcl | 218 | 606 | 69 | $2,469 |
| Kerendia Finerenone | 191 | 367 | 49 | $228K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 186 | 513 | 86 | $24K |
| Farxiga Dapagliflozin Propanediol | 182 | 385 | 50 | $205K |
| Pioglitazone Hcl Generic | 176 | 489 | 61 | $2,646 |
| Rybelsus Semaglutide | 119 | 240 | 30 | $216K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 111 | 319 | 44 | $15K |
Brand drugs: 2,823 claims; generic drugs: 3,088 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas M Fandel $3,388 ($3,388 in general payments such as food, travel and fees) from 26 companies. The largest payer was Novo Nordisk Inc with $717.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 30 | $717 |
| Amgen Inc. AMGN | 26 | $572 |
| Madrigal Pharmaceuticals MDGL | 8 | $329 |
| Lilly USA, LLC LLY | 12 | $267 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $234 |
| Dexcom, Inc. DXCM | 8 | $169 |
| Pfizer Inc. PFE | 5 | $107 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $97.98 |
| Sequel Med Tech, LLC | 1 | $85.32 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $84.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.